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Summary 
Human thymocyte differentiation was examined by injecting fetal thymic progenitor populations 
into human thymic xenografts in SCID-hu mice. Thymic progenitors were fluorescently labeled 
with the lipophilic dye PKH2. The phenotypes of their progeny could be identified by flow 
cytometric analysis of cells with a very high fluorescent PKH2 signal.  Intrathymic injection of 
purified triple negative (TN) CD3-4-8-  thymocytes resulted in the sequential appearance of 
CD3-4+8 -,  CD3-4+8 +,  and  CD3+4+8 +  cells,  with  the  subsequent appearance  of anal1 
numbers of phenotypically mature CD3 +4 +  8- and CD3 +  4-8 + ceils over a 4-d period. Sorted 
CD3-4+8 -  thymocytes  injected  intrathymically  rapidly  differentiated  to  CD4+8 +  cells. 
CD4 +  8 + fetal thymocytes in cell eycle differentiated into phenotypically mature CD3 +4+8- 
and CD3 +4-8 + populations, whereas nondividing CD4+8 + cells failed to differentiate after 
intrathymic transfer.  The number of cell divisions that occurred between the injection of TN 
thymocytes and their progeny at different time points was estimated based on the decrease in 
the intensity of the PKH2 label.  The average length of the cell cycle for the TN population 
was calculated  to be 24 h. The SCID-hu model thus provides a useful tool for studying the 
kinetics of cell division and differentiation of human thymocytes in vivo. 
A  major site of T lymphocyte differentiation is the thymus 
(for a review see reference 1). CD3-4-8-,  triple nega- 
tive (TN) 1 (or in some cases CD3-41~  [2]) thymic pro- 
genitors from the bone marrow (3), fetal liver, and yolk sac 
have been shown in mice (4, 5) and humans (6, 7) to migrate 
to the thymus where they undergo maturation and differenti- 
ation. In vivo studies of murine thymocytes have demonstrated 
differentiation of TN  thymocytes to  mature CD3+4+8 - 
and CD3 +4- 8 + single positive populations via immature 
CD3-4-8 + followed by CD4+8 + intermediates (8, 9). The 
fate of most developing thymocytes is intrathymic death, ei- 
ther early through a failure of the TCR expressed on the cell 
surface to be engaged by its self-MHC, or later in matura- 
tion through a process by which self-reactive thymocytes are 
eliminated, termed negative selection (10-13). Before or con- 
comitant to negative selection,  CD4+8+3 l~ ceils  that  are 
specific for self-MHC undergo positive selection to develop 
1Abbreviations used in  this paper: APC,  allophycocyanin;  DP,  double 
positive; NCS, normal calf serum; PI, propidium iodide; SA, Streptavidin; 
TR, Texas red. 
into T  cells that express high levels of TCR in association 
with the CD4 or CD8 coreceptor, and which are capable 
of interacting with antigen bound to self-MHC (10, 14-16). 
Thymocytes that have successfully passed through positive 
and negative selection develop into TCR  hi T calls with ma- 
ture phenotypes, emigrate to the periphery, and home to pe- 
ripheral lymphoid organs (17-19). The kinetics of call divi- 
sion and differentiation during these processes  have been 
partially defined in murine systems (20-23), and to our knowl- 
edge, have not been described for human T cell development. 
Previous descriptions of human thymocyte subpopulations 
presumably involved in differentiation in vivo have largely 
been restricted to flow cytometric analysis of antigen expres- 
sion on human fetal  and postnatal thymuses obtained at 
different points during embryogenesis and postnatal devel- 
opment (24) or immunohistochemical analysis of fetal and 
postnatal thymocytes (25),  both static models that do not 
define progenitor-progeny  relationships in a lineage. Attempts 
to study the differentiation of human TN thymocytes in vitro 
have yielded contradictory results, with some reports showing 
evidence of partial differentiation of fetal thymocytes, (26-29) 
whereas  in  other  studies,  postnatal  thymocytes failed  to 
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studies  may be due to the limitations  inherent  in in vitro 
model systems, as thymic stromal microenvironments have 
been shown to play a crucial role in mediating the differenti- 
ation of thymocytes (31-36). 
Until recently, models for an in vivo stromal microenviron- 
ment in which to study human hematopoesis and thymocyte 
differentiation were lacking. The SCID-hu mouse provides 
such a model for the in vivo study of components of the human 
immune system (37). Human fetal thymic xenografts, trans- 
planted under  the SCID  mouse kidney capsule with  frag- 
ments of fetal liver, develop into thymic organs that have a 
similar histology to that of human postnatal thymus (37, 38), 
and provide a system where dynamic events ofT cell differen- 
tiation can be measured  (39). 
We herein report studies on the in vivo differentiation of 
purified human T  cell progenitor populations that were in- 
jected intrathymicaUy into allogeneic human thymic xenografts 
in SCID-hu mice. To identify injected donor thymic progen- 
itors, injected cells were labeled with PKH2, a stable, fluores- 
cent dye that incorporates into the cell membrane.  The in- 
tensity of PKH2 fluorescence was  shown  to be dependent 
upon the number of call divisions that foUowed labeling. Anal- 
ysis of the relative fluorescence of PKH2 +,  donor-derived 
cells in the SCID-hu thymus and their pattern of CD3, CD4, 
and CD8 expression elucidated the frequency of cell division 
and at least one pathway of differentiation from CD3-4-8- 
thymocytes to those with more mature phenotypes. The results 
show that in this model, human fetal TN thymocytes have 
the capacity for self-renewal, as well as differentiation via a 
CD3- 4 + 8-  intermediate, to CD3- 4 + 8 +/CD3 +  4 + 8 + pop- 
ulations  and mature CD3+4+8 -  and CD3+4-8 +  subsets. 
Materials and Methods 
Mice.  SCID-hu mice were prepared as previously  described (38) 
by engrafting small fragments of human fetal thymus and liver grafts 
under the left kidney capsule of 4-6-wk-old C-B17 sold~stir mice. 
Fetal liver served as a source of hematopoetic progenitor cells. SCID- 
hu mice were maintained under filter tops in the Stanford Univer- 
sity research animal care facility. Tissues were obtained from aborted 
fetuses of 17-22 wk gestational age after consent of the patients 
and approval of the Institutional Review Board of Stanford Univer- 
sity Medical Center on the use of Human Subjects in Medical Re- 
search. Engrafted mice were used 2-4 mo after engraftment, a time 
at which the human thymic tissue  had grown to more than 100 
times the original volume (40). 
mAbs and Fluorescent Reagents.  Murine antibodies to human 
CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD19, CD20, CD25, 
CD30, CD34, CD38, CD43, CD45, Leu-8, and HLA-DR were 
obtained from Becton Dickinson & Co.  (San Jose, CA).  Strep- 
tavidin-conjugated Texas red (SA-TK) and allophycocyanin  (APC) 
were purchased from Caltag Laboratories (San Francisco, CA). APC- 
anti-CD5 was a generous gift of Drs.  Neelima Bhat and Aaron 
Kantor (Stanford University Medical School, Stanford, CA). FITC 
anti-CD34 and APC-conjugated anti-CD8 were gifts of Dr. Leon 
Terstappen  (Becton Dickinson & Co., San Jose, CA). 
Isolation of Fetal Thymocyte Subpopulations.  TN thymocytes were 
enriched by negative selection before flow cytometric cell sorting 
by magnetic bead depletion of mature thymocytes as described in 
detail elsewhere (8, 41, 42). Briefly, thymocytes suspended at 2  x 
10S/ml in  5  mmol/liter HBSS,  pH  7.4 containing 5%  vol/vol 
heat-inactivated normal calf serum (NCS), and 0.02% wt/vol so- 
dium azide (Gibco Laboratories,  Grand Island, NY) were depleted 
of marker positive cells by incubation with biotinylated mAbs to 
CD3, CD4, and CD8, followed by the addition of paramagnetic 
beads coated with SA (100/al/10  s cells; Advanced Magnetics,  Inc., 
Cambridge, MA) for 30-60 min at 4~  with constant mixing. 
Bead-coated thymic cells were then removed by magnetic separa- 
tion, and the remaining cells restained with biotinylated antibodies 
to  CD3,  CD4,  and  CD8,  followed by SA-TR.  To enrich  for 
CD3-4+8 -  cells, magnetic bead depletion with biotinylated anti- 
CD3 and anti-CD8 mAb was followed by staining with SA-TR 
and PE anti-CD4. CD3- 4- 8- and CD3- 4 +  8- cells were sorted 
separately by setting the appropriate electronic gates for CD3-8- 
cells  and  sorting  either PE-negative (CD3-4-8-  cells)  or  PE- 
positive populations  (CD3-4+8 -  cells).  FITC-conjugated anti- 
CD45 or APC-conjugated anti-CD5 mAbs were included in the 
final staining step in order to identify the T cell progenitors (which 
are CD45 I~ and CD5  t~ in the CD3-4-8-  TN population. Most 
of the thymic B cells and all of the thymic macrophages in the 
fetal thymus were excluded  from sorts of T  cell progenitors, by 
virtue of their lack of expression  of the CD5 marker (in the case 
of conventional CDS-  B cells and macrophages) or their higher 
level of CD45 expression than CD3-4-8-  T cell progenitors (in 
the case of all thymic B cells and macrophages). In some experi- 
ments in which APC-conjugated anti-CD5 mAb was used to iden- 
tify the T cell progenitors, a low level of contamination of the TN 
population with  CD5 §  thymic B cells could not be excluded. 
However, separate FACS  |  analyses (Becton Dickinson & Co.) in- 
cluding  a  variety of T  and  B  cell  markers,  demonstrated  that 
CD5  l~ CD19 +  thymic  B  cells  comprise  <11%  of the  CD5  I~ 
CD3-4-8- TN population. TN and CD3-4+8-  cells were sorted 
by setting appropriate electronic gates with the highly modified 
dual-laser FACS  |  system (Becton Dickinson & Co.) equipped with 
a four-decade logarithmic amplifier (43). When PKH2 cell labeling 
preceded cell sorting, electronic gates in the FITC channel were 
set in such a way that a homogeneously labeled, highly fluorescent 
population was obtained (see below). After sorting, an aliquot of 
the sorted cells was reanalyzed, and in all experiments described, 
the degree of purity was  />98%. 
PKH2 Labeling of Thymocytes.  Just before or after cell sorting, 
TN-enriched,  bead-depleted  thymocytes  or  sorted  TN  and 
CD3-4+8 -  cells,  respectively,  were labeled  with  4  gM  PKH2 
(Zynaxis Cell Science Inc., Malveru, PA), a stable, fluorescent dye 
that incorporates into the cell membrane. PKH2 has an excitation 
peak of  490 nm and an emission peak of 504 nm. The FITC fluores- 
cence channel was used to measure PKH2 levels. Thymocytes la- 
beled with 4 gM PKH2 have a fluorescence in the FITC channel 
more than 10 times that of cells labeled with saturating concentra- 
tions of directly conjugated FITC mAb such as FITC-anti-CD4. 
Thymocytes in conical, polypropylene tubes were washed once at 
room temperature in HBSS or PBS containing no serum or so- 
dium azide. Cells were then resuspended in Zynaxis buffer A (1-2 
x  106  thymocytes/ml) and  an  equal  volume of 8  gM  PKH2 
(diluted in buffer A) was added to the cells. Cells were incubated 
in the resultant 4/~M  PKH2 with frequent mixing for 2 min. 
Staining was terminated by adding an equal volume of NCS, fol- 
lowed by dilution of labeled cells with HBSS. PKH2-1abeled cells 
were then washed three times by dilution with HBSS, underlaying 
with NCS, and centrifugation for 10 min at 4~  200 g, before 
FACS  |  sorting or injection into SCID-hu thymic xenografrs. 
Intrathymic Injections.  SCID-hu mice were anesthetized with a 
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Shawnee, KA) and Ketaset (ketamine HC1, 83/~g/g body weight; 
Parke-Davis,  Morris Plains, NJ). The SCID-hu thymus graft that 
had been previously placed beneath the capsule of the left kidney 
was exposed via a lateral incision and injected with 10s-106 sorted, 
PKH2-1abeled thymocytes in 10-30 ~1 of HBSS using a gas-tight 
syringe (Hamilton Co., Reno, NV) and a 30-gauge needle. Sham- 
injected control grafts were injected with HBSS alone. The wound 
was then closed with a 4-0 nylon suture and surgical  staples. 
Flow Cytometric Analysis of Human Thymocytes  from SCID-hu 
Mice.  Cell surface staining and flow cytometric analysis of lym- 
phoid cells was performed with cell suspensions of SCID-hu thymus 
xenografts that had been injected previously with sorted, PKH2- 
hbded progenitor populations. Cells were labeled with saturating 
concentrations ofbiotinyhted anti-CD3 plus SA-TR, PE-conjugated 
anti-CD4, and APC-conjugated anti-CDH,  or unlabeled anti-CD3 
followed by goat anti-mouse Ig TR, PE anti-CD4, and biotinylated 
anti-CD8 plus SA-APC. At each staining step, antibodies were mixed 
with cells at 4~  for 20 min in HBSS containing 5% NCS in 50-200 
/~1 vol. Muhicolor immunofluorescent analysis of cell suspensions 
in HBSS/NCS (plus  1 #g/m1 propidium iodide (PI), or without 
PI for fixed cells and those combinations of labeled antibodies using 
both the PE and APC channels) were performed by FACS  |  In 
three-color analysis, dead cells were excluded from the analysis by 
normal scatter gating methods and by setting electronic gates to 
exclude PI-positive cells (43). In four-color analysis, dead cells were 
excluded only by forward and obtuse scatter gating.  Computer- 
generated contour plots from fluorescent measurements of viable 
cells were used to present the two-color staining patterns.  The 
number of contour lines drawn in a particular area represents the 
frequency of cells exhibiting a given level of fluorescence,  where 
the area contained between any two lines represents 5% of the total 
cell population. The contour plots are labeled according to the es- 
tablished names of the molecules detected by the particular anti- 
bodies (e.g.,  CD4,  CD8). 
Detection of  Donor-derived  Thymocytes.  Because of the small pro- 
portion of donor-derived cells in SCID-hu grafts,  PKH2-positive 
cells made up <0.5% of cell suspensions  from intrathymically in- 
jected SCID-hu grafts.  Analysis of donor-derived PKH2-positive 
cells was achieved by collecting data on cells with a mean PKH2 
fluorescent signal  of more than 25 (channel 140), which was 40 
times greater than that of the mean fluorescent signal of unlabeled 
thymocytes (0.6; channd 30 _+ SD 20 channels), using a four-decade 
scale divided into 250 channels such that a difference of 70 channels 
represents a 10-fold difference in fluorescent signal intensity, and 
a difference of 20 channels represents a twofold difference in the 
mean fluorescent signal intensity. Less than .002% (1/50,000) of 
lymphoid cells in sham-injected control thymus grafts had fluores- 
cent signals  greater than the threshold of 25 (channel 140). For 
analysis of PKH2-1abeled  cells, cells with PKH2 fluorescence  of 
greater than 25 were counted as being derived from the injected, 
PKH2-1abeled thymocytes. Cells from injected thymic grafts were 
analyzed for CD3, CD4, CDH, and the signal intensity of the PKH2 
label. PI and forward and obtuse scatter gates were used to exclude 
dead and nonlymphoid cells. 
Hoechst Staining and Sorting for Dividing CD4+8 + Thymocytes. 
To  differentiate  and  sort  between  nondividing  and  dividing 
CD4 *8 + thymocytes, fetal thymocytes were labeled with the vital 
DNA  stain,  HOECHST-33342 (bisBenzimide H-33342;  Sigma 
Chemical Co., St. Louis, MO) (44). Thymocytes were first labeled 
with FITC-conjugated anti-CD4 and PE-CDH. Cells  were con- 
centrated by centrifugation, then resuspended in HBSS without 
sodium azide, and warmed to 37~  for 15 min. HOECHST 33342 
dye and PI were then added at final concentrations of 5 and I/~g/ml, 
respectively. After a 30-min incubation at 37~  cells were sorted 
for CD4§  + HOECHST-negative (cells in  G0-1)  and -positive 
(cells in S/G2+M, with greater than 2N DNA content) by setting 
and appropriate electronic gates. Sorting was performed with a FAC- 
Star II  |  flow cytometer (Becton Dickinson & Co.) equipped with 
two argon lasers, one emitting at 488 nm for detection of FITC, 
PE,  and  PI,  and the other in  the  UV  region for detection of 
HOECHST 33342.  Dead cells were excluded by gating on for- 
ward and obtuse scatter and PI. 
Results 
PKH2 Signal Intensity Can Be Used to Measure the Rate of 
CellDivision.  The relationship between the decline of fluores- 
cence signal from PKH2-1abeled cell populations and cell di- 
vision was established in vitro by labeling a human B  cell 
lymphoma cell line (LM919) (Waller, E. K., unpublished ob- 
servations) with PKH2 and measuring the number of labded 
cells and their PKH2 signal intensity at various times there- 
after.  Each  doubling  of the  number  of labeled  cells  cor- 
responded to a 50% drop in the mean fluorescent signal as 
the dye present in the plasma membrane of the parent cell 
was divided among two daughter cells (Fig. 1). Others have 
observed the same relationship with PKH2 labeling and di- 
vision kinetics (45), and have also demonstrated that (a) the 
PKH2 dye results in uniform staining of the plasma mem- 
brane; (b) the dye does not leak out of cells; (c) it is not trans- 
ferred from cell to cell within the same culture; and (d) the 
growth rate and metabolic activity of PKH2-1abeled cells are 
unaffected compared with  unstained  controls  (46). 
PKH2-1abeled Human  Thymocytes  Injected into SCID-hu 
Thymic Xenografis Were Identified as a Distinct, Highly Fluores- 
cent Population upon Analysis by Flow Cytometry.  Intrathymi- 
cally injected thymocytes (enriched for immature TN thymo- 
cytes to a purity of 50% by CD3, CD4, and CD8 magnetic 
bead  depletion  and  labeled  with  PKH2)  could  be  easily 
identified in the FITC channel as a separate, highly fluores- 
1000 . 
I  2  3 
Number  of Cell Divisions 
Figure 1.  PKH2 signal correlates with cell division. A human B cell 
lymphoma cell line (LM919) was labeled with either 4/~M (upper  curve) 
or 2 #M (lower  curve) PKH2 and plated in separate wells of a 24-well dish 
at a concentration of 5  x  106/mI. At 24 h, the cells in one well were 
counted, and their mean PKH2 signal intensity was determined by flow 
cytometry. The number of cell divisions was determined by calculating 
for y (cells/ml = original No. of cells/ml * ey) where y divided by 0.693 
= number of divisions. The fractional decrease  in PKH2 signal intensity 
per cell division was calculated from an exponential curve fit. 
267  Kraft et al. cent population at various time points after injection (Fig. 
2).  In this experiment,  the fraction of PKH2-1abeled cells 
varied between 1 and  10%  of the total thymocytes in the 
injected grafts. The signal intensity of fluorescently labeled 
cells (represented as the mean fluorescent signal of the popu- 
lation  of PKH2 + cells)  declined exponentially  with  time, 
suggesting that cell division was occurring within the PKH2- 
labeled population. 
Developmental Potential of CD3-4-8-  Thymocytes In Viva 
To determine the developmental fate of thymocytes at defined 
stages of differentiation,  different thymic populations were 
sorted to a purity of >98%, PKH2 labeled, and injected into 
SCID-hu thymic grafts.  The TN cells,  present in the fetal 
thymus at a frequency of 1-4% (Fig. 3 A), were sorted (Fig. 
3 B) and analyzed for their expression of CD34. At least 50% 
of sorted TN cells were CD34 + (Fig. 3 C). TN cells were 
labeled with PKH2 (Fig.  3 D) and injected into the thymic 
grafts of SCID-hu mice. The pattern of CD3, CD4, and CD8 
expression on the PKH2-1abeled population of fetal thymo- 
cytes was determined at 12, 24, 48, 72, and 96 h after their 
injection into thymic grafts. Data from a control graft ana- 
lyzed without a gate on PKH2 + cells (Fig. 3 E), a graft ana- 
lyzed 24 h after injection (with an electronic gate to display 
the phenotype of PKH2 + cells)  (Fig.  3 F) and a graft ana- 
lyzed  48  h  after  injection  (Fig.  3  G)  are  shown  from  a 
representative  experiment.  The  pattern  of differentiation 
from  several  experiments  was identical:  the  rapid  appear- 
ance of a CD3-4+8 -  population followed by CD3-4+8 + 
and CD3+4+8 + populations,  and the appearance of small 
numbers  of  phenotypicaUy  mature  CD3 +4- 8 +  and 
CD3+4+8 -  cells.  The data from six separate experiments 
were similar and are summarized in Fig. 4. The fraction of 
PKH2-1abded thymocytes recovered that remained TN (Fig. 
4 A) decreased from 100% at the time of injection, to a mean 
of 90% at 12 h, 55% at 24 h, 29% at 72 h, and 7% at 96 h. 
The initial appearance,  after 12-24 h, of a CD3- 4 +  8- popu- 
lation (Fig.  4 B) suggest that TN thymocytes differentiate 
in vivo via a CD3-4 +  8-  intermediate population.  The in- 
crease in the fraction of PKH2-1abeled thymocytes recovered 
that were CD3-4§  -,  was followed by an increase in the 
fraction  of PKH2 +  cells  that  were CD4+8 +  (Fig.  4  C). 
Small numbers of PKH2-1abded, donor-derived thymocytes 
with  mature  phenotypes (CD3*4+8 -  and 3+4-8 +)  were 
apparent by 48 h  (Fig.  4 D). Their percentage of the total 
population of donor-derived PKH2-1abded cells approached 
the relative frequency of these cells in the normal  thymus. 
CD3-4+8 -  Thymocytes Differentiate to CD4+8 + Thymo- 
cytes In  Viwx  If the  CD3-4+8 -  population  is a true  se- 
quential  intermediate  between  TN  and  CD4+8 +  double 
positive (DP)  thymocytes in human  T  cell differentiation, 
it should be present in normal  human  fetal  thymus.  Flow 
cytometric analysis  of both fetal  and SCID-hu thymocytes 
revealed the presence  of a significant  CD3-4+8 -  population 
(2-4%  of  thymocytes)  (Fig.  5  A,  CD4+8 -,  upper  left 
panel, and Sen-Majumdar,  A., Stanford University Medical 
Center, Stanford, CA, unpublished observations). Significant 
numbers of CD3-4-8 + cells were not detected in analysis 
of human  fetal thymus  (Fig.  5 A,  CD4-8 +,  lower right 
panel). Further characterization  of human fetal CD3 - 4 +  8- 
thymocytes  revealed  these  cells  to  be  CD1 +,  CD2 +, 
CD5 mr-hi,  CD7 +,  CD38 +,  CD43 +,  CD45 +,  CD10-, 
CD15-,  CD20-,  and  CD25-,  and predominantly  HLA- 
DR-  and L-sdectin (Leu-8)-. As CD4 expression increases 
in  the  CD3-8-  population,  there was a concomitant  de- 
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Figure  2.  (.4)  5  x  106 PKH2-labeled 
fetal thymocytes enriched for TN (to a pu- 
rity of 50% by bead depletion) were injected 
into separate SCID-hu thymic grafts.  At 
various time points after injection, thymo- 
cytes from injected and control grafts were 
analyzed  for their PKH2 signal intensity 
(B-E).  To simplify data analysis, only data 
on cells with a PKH2 signal greater than 
6 (channel  100) were collected (B,  inset). 
Thymocytes from  sham-injected control 
thymuses  never  had a  significant  PKH2 
signal greater than 25 (channel  140) (F). 
The percentage  of thymocytes from each 
graft with a PKH2 signal greater than 25 
(channel  140) is shown in each panel (top 
right). (Bottom)  Absolute mean fluorescent 
signal intensities (on a scale of 0.1-1,000). 
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Figure  3.  CD3-4-8- thymocyte differentiation in vivo. A representative experiment in which a 20-wk fetal thymus (,4) was sorted for TN thymo- 
cytes, as described in Materials and Methods.  The TN cells were sorted and reanalyzed by FACS  |  (B). 50% of the TN cells expressed high levels 
of CD34 (C). These sorted TN cells were uniformly  labeled with PKH2 (/9) and were injected intrathymically into the thymic xenografts of SCID-hu 
mice. The CD4 vs CD8 profile of all thymocytes in the recipient graft (E), and the profiles of PKH2 + , donor-derived thymocytes from grafts analyzed 
at 24 (F) and 48 (G) h are shown. The density profile of PKH2 signal of injected grafts is shown (F and C, inset)  and the fraction of thymocytes 
that were PKH2 + (and therefore, donor derived) is shaded. The relative percentages of recovered PKH2 + thymocytes of different phenotypes are shown 
in each quadrant.  At 24 h the ratio of CD3-  to CD3 + in the PKH2 + CD4*8 -  population was 88:12; the corresponding  ratio  for the CD4+8 + 
population was 77:23. At 48 h the ratios of CD3-  to CD3 + cells had decreased to 70:30 (CD4+8 -) and 71:18 (CD4+8+). 
100 
~u  75.  =o 
>=  5o 
~  25. 
~  75. 
~  50. 
~  25, 
C  CD4+8+ 
B  CD3  "4+8" 
20 
15 
10 
CD3+4+8  - 
￿9 CD3+4"8  + 
HOURS 
Figure  4.  In  vivo  differentiation  after  transfer  of  PKH2-1abded 
CD3-4-8-  TN fetal thymocytes to SCID-hu thymic xenografts.  The 
TN subpopulation of fetal thymocytes was sorted and labeled with PKH2 
as described in Materials and Methods. At 12, 24, 48, 72, and 96 h after 
intrathymic  transfer, thymocytes from the recipient thymus were analyzed 
for expression of CD3, CD4, CD8, and PKH2 label by four-color flow 
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crease in expression of CD34,  a marker of human hemato- 
poietic  precursor  cells  (24,  47),  such  that  CD3-4hi8- 
thymocytes  were predominantly  CD34-  (Fig.  5 B). 
Fetal  CD3-4+8 -  thymocytes were  sorted,  labeled with 
PKH2, and injected intrathymicaUy into SCID-hu xenografts. 
The  majority  of PKH2-1abeled  3-4+8 .  cells  underwent 
rapid differentiation into both CD3-4+8 + and CD3+4+8 + 
cells (Fig. 6), with over 67% of the recovered PKH2-1abeled 
thymocytes expressing both the CD4 and CD8 markers 48 h 
after intrathymic injection. Small numbers of donor-derived, 
phenotypically  mature  CD3-4+8 -  and  CD3+4-8 +  cells 
were  evident  after  24-48  h  in vivo. 
The Subpopulation  of CD4+8 +  Thyraocytes  in  Cell  Cycle 
Differentiate  to  Mature  CD3*4+8 -  and  CD3+4-8 +  Cells 
whereas Nondividing  CD4+8 + Cells Fail to Differentiate  Pre- 
vious work from this laboratory (10) demonstrated in mu- 
cytometry. Data Were  gated for PKH2 positive, donor-derived cells (PKH2 
signal intensity >25; channel 140). Percentages represent the mean frac- 
tion of PKH2 positive, donor-derived thymocytes expressing different T 
cell phenotypes that were recovered at various time points after TN injec- 
tion. Error bars represent SD. CD4+8- 
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Figure  5.  CD3-4+8 - cells constitute a small population in the normal human fetal thymus. (A) The CD3 profiles ofCD4  8  , CD4+8  , CD4+8 +, 
and CD4-8 + thymocytes  are shown, with the percentages of CD3  and CD3 + cells shown. (B) The C34 and CD4 profile of the CD5§  - popu- 
lation of fetal thymocytes. 
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Figure  6.  CD3  4+8 -  thymocytes differentiate intrathymically into 
CD4+8 + thymocytes.  Sorted, PKH2-1abeled CD3  4+8 - fetal thymocytes 
were injected into SCID-hu thymic grafts. Donor-derived  thymocytes  were 
analyzed by flow cytometry 24 and 48 h after injection. The fraction of 
recovered PKH2-1abeled, donor-derived  thymocytes  in each thymocyte  sub- 
population at each time point is shown. Values are derived from the means 
of three separate experiments. 
rine thymocyte development  that  CD4 +  8 § blast cells  pos- 
sessed the capacity to differentiate into mature cells,  whereas 
small, nonblastic DP thymocytes remained DP or died in vivo. 
We isolated dividing CD4 + 8 + human fetal thymocytes by 
sorting those DP thymocytes with greater than 2 N  DNA 
content  (in  S/G2+M)  as  measured  by HOECHST  33342 
staining  (Fig.  7 A).  Cells  containing >2 N  DNA content 
had a  scatter  profile consistent  with  that  of dividing cells, 
and were larger than cells with 2 N  DNA content (data not 
shown).  Sorted, HOECHST 2 N  PKH2-1abeled 4+8 + cells 
were observed to remain predominantly DP thymocytes when 
analyzed up to 48 h after IT injection into SCID-hu thymus 
grafts  (Fig.  7 B).  Less  than  5%  of the  donor-derived cells 
recovered after  transfer  had  differentiated  to mature  single 
positive phenotypes. Sorted CD4 + 8 + that were in cell cycle 
(HOECHST-positive cells with >2 N  DNA content) showed 
evidence of differentiation into both CD3 +  4- 8 + (13.7%  of 
the recovered PKH2 + cells)  and 3+4+8 -  (12.3%  of the re- 
covered PKH2 + cells)  phenotypically mature single positive 
populations  (Fig.  7  C). 
Cell Division Kinetics of CD3-4-8-  Thyrnocytes.  The de- 
cline in fluorescent signal intensity of PKH2-1abeled cells cor- 
responded with the number of cell divisions those cells had 
undergone (Fig.  1),  and therefore it is reasonable to assume 
that the decline in PKH2 label intensity with time could be 
270  In Vivo Differentiation of Human Thymocytes loo 
(.j  80- 
~  60 
Z  40 
~  20 
~.  CD4+8+ 
G1  S+G2,tM 
CD4 
Figure  7.  CD4+8 + thymocytes in cell cycle differentiate to mature 
CD3+4+8 -  and CD3§  8 + cells whereas nondividing CD4+8 § cells 
fail to differentiate after transfer to SCID-hu thymus grafts. (A) CD4+8 § 
HOECHST 33342 labeled thymocytes  were sorted on the basis of DNA 
content. After sorting and labeling with PKH2, HOECHST 2 N (G0- 
G1) and HOECHST >2 N (S/G  2  +M) CD4+8 + thymocytes  were injected 
into SCID-hu thymic grafts. 48 h later, injected grafts were analyzed and 
the CD4 vs. CD8 profile of PKH2+, cells derived from donor DP 2 N 
(B) and DP HOECHST >2 N cells (C) is shown. Numbers in each quad- 
rant show the percentages of respective donor-derived populations. 
used to estimate the rate of cell division for defined human 
thymocyte populations.  The mean fluorescent signal of the 
donor-derived PKH2-1abeled TN cells declined exponentially 
with respect to time after intrathymic injection, and the de- 
cline in the natural logarithm of the mean fluorescent signal 
of the PKH2-1abeled cells that remained TN was nearly linear 
in each experiment  (Fig.  8 A). However, the data points in 
Fig. 8 A  did not fit perfectly on a straight line. In particular, 
the initial slope of the line connecting the first two data points 
in each experiment  was  steeper  than  the line  that  was the 
best  curve fit  for all the data points.  These data were best 
approximated by a series of second degree polynomial equa- 
tions,  in  whichy  =  c,x 2  -  (re,x)  +  b,  whereyis  the 
ln[PKH2 signal] at time x, b is the ln[PKH2 signal] at time 
0, and c and m are constants related to the rate of cell division 
in the TN population, and the fraction of cells in cell cycle, 
and x  is time, in days. We calculated that the initial decline 
in the ln[PKH2 signal]  during the first  24 h  from a mean 
of five experiments to be  -0.7  _+ 0.17 ln[PKH2 signal]/day, 
which corresponds to a 50% decrease in the PKH2 signal/day, 
and a calculated cell cycle length for the TN population of 
24  _+  6 h (the PKH2 signal decreases 50% during each cell 
division;  Fig.  1).  This calculation assumes that the PKH2- 
labeled TN population is homogeneous with respect to the 
rate of cell division and the fraction of cells in cell cycle during 
the  first  24-h period  after  injection. 
To  compare  the  number  of cell  divisions  that  thymo- 
cytes  of  various  phenotypes  (CD3-4-8-,  CD3-4+8 -, 
CD3- 4 § 8 +, CD3 § 4 § 8 § ) had experienced during their dif- 
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Figure  8.  The mean PKH2 signal intensity in TN donor-derived populations decreased over time. (A) The natural logarithm of the PKH2 fluores- 
cence signals from five separate experiments in which several SCID-hu grafts were injected with the same population of PKH2-1abeled TN thymocytes 
and analyzed at different time points are plotted. The initial intensity of PKH2 labeling in the TN population varied by experiment. The data points 
were best modeled by second degree polynomial equations in which the decline in the ln[PKH2 signal] initially is nearly linear during the first 24 h, 
and is then followed by a progressively lower rate of decline over the next 3 d. The initial slopes of the decline in the ln[PKH2 signal] for the TN 
population were calculated for each experiment at 24 h, with a mean value of -0.7 _+ 0.17 ln[PKH2 signal]/day, which is equivalent to a 50% decrease 
in the PKH2 signal/day, and yields an estimated cell cycle length for the TN population of 24  _+  6 h (the PKH2 signal decreases 50% during each 
cell division; Fig. 1). (Dashed line) Highest level of  background fluorescent signal measured in control thymic grafts. (B) The mean PKH2 signal intensity 
of donor-derived thymocyte population at 24 h as a fraction of the initial PKH2 signal intensity of the TN thymocytes that were injected into the 
SCID-hu thymus graft. 
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Figure  9.  A model for the differentiation of CD3 - 4- 8 - 
human fetal thymocytes. Some TN thymocytes show evidence 
for self-renewal. Other TN thymocytes differentiate to a rap- 
idly dividing CD3-4+8 -  population, which results in sub- 
sequent appearance of CD3- 4 +  8 + and CD3 +  4 +  8 + popu- 
lations.  Most  of  the  CD3+4+8+  population  undergoes 
intrathymic death whereas a fraction differentiate into ma- 
ture CD3+4*8 -  and CD3+4-8 +  thymocytes. 
ferentiation from PKH2-1abeled TN cells, their mean fluores- 
cent (PKH2) signals were calculated as fractions of the initial 
fluorescent signal of the PKH2-1abeled TN thymocytes that 
had been previously injected. Whereas the fluorescent signal 
of the TN cells declined at a nearly constant exponential rate 
in each experiment, presumably as a result of their cell divi- 
sion (Fig. 8 A), some of their thymic progeny showed a greater 
rate of decrease in their PKH2 signals. As shown for donor- 
derived thymocytes analyzed 24 h after intrathymic injection, 
the PKH2 signal in the TN population declined to 50% of 
that  of the input cells, whereas  the PKH2  signal of the 
more  mature  thymocyte  subpopulations  (CD3-4+8 -, 
CD3-4+8 +,  CD3+4+8+)  had declined to  '~30%  of the 
input value (Fig. 8 B), suggesting that, on the average, these 
cells had undergone approximately one more cell division than 
the corresponding TN cells. 
Discussion 
This study provides direct information regarding the pheno- 
types and differentiation pathway of human thymic progen- 
itors in vivo. In this report, we have transferred T cell pro- 
genitors at defined stages of development into SCID-hu thymic 
grafts  and described their intrathymic differentiation into 
phenotypically  more mature populations. We used the fluores- 
cent dye, PKH2, to mark donor cells and their progeny in 
vivo and to distinguish them from the unlabeled thymocytes 
present in the SCID-hu thymic grafts. Congenic markers are 
not available for human thymocytes, such as Thy 1.1 and 1.2 
used in routine studies (8, 9), nor was it feasible to identify 
thymic T cell progenitors through the use of host/donor HLA 
mismatch, (used to distinguish mature progeny of CD34 +, 
hematopoetic stem cells in long-term reconstitution assays 
in SCID-hu mice [48]) because of the low expression of HLA 
by immature thymocytes. 
The  system of marking  thymic progenitors  and  their 
progeny with PKH2 has the advantage of being easy to per- 
form and results in the fluorescent marking of donor-derived 
cells in a way that allows an approximation of the number 
of cell divisions they have undergone. However,  we noted 
three technical limitations with this method. First, only a 
finite number of cell divisions can be followed in labeled 
progeny before the level of PKH2 signal intensity becomes 
indistinguishable from that of background fluorescence (Fig. 
8 A), and the variance in the PKH2 signal intensity in the 
donor-derived thymocytes increased with time. Cells with 
an initial mean PKH2 fluorescence of 320, for example, could 
undergo four cell divisions before dilution of the PKH2 in 
derivative cells would fall below the highest level of back- 
ground autofluorescence seen in host thymocytes. The vari- 
ance in the mean PKH2 signal of different thymic subsets 
can be attributed to the variance in the original PKH2 staining 
intensity of the labeled TN population and a variable number 
of cell divisions that occurred between the PKH2-1abeled TN 
and their progeny. 
A second technical drawback to this system, though not 
directly related to PKH2 staining, was that the recovery of 
PKH2-1abeled TN cells and their progeny was low. Since each 
thymus graft contained different numbers of total thymo- 
cytes, and the actual number of PKH2 + cells injected suc- 
cessfully into the graft varied among different grafts within 
a given experiment, the absolute numbers of PKH2 + cells 
and their fraction of the total thymocyte population [number 
injected/(number injected +  number host thymocytes)] varied 
considerably,  After injection of a mean (+  SD) of 248,000 
+  117,000 PKH2-1abeled TN into thymic grafts that con- 
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number  of PKH2-1abeled  cells  that  could be  detected at 
different time points in thymic grafts varied from a mean 
of 27,340  _+  3,400 cells at 12 h' (a recovery of 16%  of the 
number of PKH2 + cells injected) to 19,280  _+ 9,500 at 24 h 
(11.2% recovery); 11,799 _+ 6,200 at 48 h (10.2% recovery); 
25,860  _+  17,100 at 72 h  (7.4%  recovery); and 21,800  _+ 
9,200 at 96 h (6.7% recovery). These data indicate that only 
about  10-20%  of the pKH2-1abeled TN cells that we at- 
tempted to inject into the graft remained as viable cells at 
12 h, and their PKH2-1abeled progeny constituted a slowly 
declining fraction of the total thymocytes in the graft there- 
after.  The large initial loss of PKH2-1abeled cells immedi- 
ately after intrathymic injection suggests that a majority of 
the injected cells fail to remain in the thymus (they leak out 
of the injection site), or that they die soon after injection, 
an observation that is true for direct in situ intrathymic in- 
jection studies (49). 
The failure to observe an accumulation of PKH2-1abeled 
cells 12-96 h after intrathymic injection may be due to the 
emigration of mature thymocytes into the peripheral circula- 
tion of the SCID-hu mouse (17,  18, 37); their intrathymic 
cell death, either at the level of CD31~  + cells (due to the 
failure of antigen-presenting cells to engage the TCR [16]), 
or at the level of CD3 +  4 +  8-  or 3 +  4- 8 + (due to negative 
selection) (10); or a competition between the self-renewal of 
PKH2-1abeled TN and the endogenous production of TN 
thymocytes within  the  SCID-hu  thymic graft.  SCID-hu 
thymic grafts contain an admixture of thymocytes and pluripo- 
tent hematopoetic stem cells (7) derived from fragments of 
fetal liver, and thus have a relatively constant supply of new 
TN thymic progenitors. Therefore we would predict that the 
proportion of PKH2-1abeled thymocytes would diminish over 
time  as  PKH2+-labeled  TN  cells  mature,  differentiate, 
and/or die, and are replaced by unlabeled TN cells derived 
from fetal liver hematopoetic stem cells. 
The third technical point concerning this system was that 
we studied the differentiation of fetal thymocytes in heterol- 
ogous (HLA mismatched) thymus grafts in SCID mice. We 
used fetal thymus as a source of thymic progenitors because 
they contained greater numbers of immature thymocytes than 
were present in established SCID-hu grafts. The differentia- 
tion of hematopoetic stem cells to mature T cells after their 
injection into heterologous thymic grafts has been demon- 
strated (50), indicating the ability of thymocyte progenitors, 
mismatched with respect to their expression of HLA antigens 
compared with the recipient thymus (51), to differentiate nor- 
mally in SCID-hu mice (6, 48).  In these experiments, the 
mature, donor-derived thymocytes had normal phenotypes 
and were tolerant to the HLA presented by the thymic-host 
stromal environment (52).  Nevertheless, the differentiation 
ofT cell progenitors in an aUogeneic, HLA mismatched thymic 
microenvironment might differ from the differentiation of 
T  cell progenitors in an autologous thymic microenviron- 
ment. Therefore, we sorted TN thymocytes from SCID-hu 
grafts, labeled them with PKH2,  and injected the PKH2- 
labeled TN cells into SCID-hu mice that had been grafted 
with thymic tissue from the same fetal donor. We found im- 
mature  TN  thymocytes  made  up  a  smaller  proportion 
(<0.2%)  of thymocytes in SCID-hu grafts 2 mo after en- 
graftment as compared with 1-3% TN cells of human fetal 
thymus. The differentiation of the limited number of TN 
cells that could be sorted from SCID-hu grafts occurred in 
an identical pattern as that we have observed with fetal thymo- 
cytes (data not shown). 
CD34  has  been  shown  to  be  a  marker  of  human 
hematopoetic stem cells (6, 24, 47, 48) as well as the earliest 
thymic T cell progenitor (24).  We characterized the pheno- 
type  of the  TN  and  CD3-4+8 -  progenitors  from  fetal 
thymus with respect to their expression of CD34 and other 
lymphoid markers. We found that TN thymocytes expressed 
intermediate levels of the CD5,  CD45,  and HLA-DR an- 
tigens (CD51~176  Greater than 50% of the 
sorted TN cells were CD34 + and lacked significant expres- 
sion of HLA class I antigens. In contrast, more mature T 
cell phenotypes were CD34-  CD5 hi, and CD45 ~. CD34 ex- 
pression was inversely correlated with CD4 expression (Fig. 
5 B). Low levels of CD4 expression have recently been de- 
scribed on a population of murine pluripotent hematopoi- 
etic stem cells (53).  CD34 + cells present in the CD3-41~ 
population (which fell between TN and CD3-4+81  cells, 
the latter being CD34-) could warrant consideration in fu- 
ture studies of human thymocyte differentiation. 
We observed the maturation of CD3-4-8-  progenitors 
to more mature thymocytes in vivo, with the sequential ap- 
pearance of CD3-4+8 -,  3-4+8 +, 3+4+8+,  3+4+8 -,  and 
3+4-8 + populations over 12-96 h.  Differentiation of mu- 
fine TN to mature thymocyte subsets in vitro, on short-term 
thymic stromal cultures, has also recently been shown to occur 
within 2  d  (54,  55).  Using the system of PKH2-1abeling 
thymocyte progenitors, we have observed differentiation of 
the most immature (TN) thymocyte to cells with the most 
mature (single positive) phenotype. At 24, 48, and 72 h after 
injection of PKH2-1abeled TN,  there were approximately 
twice as many PKH2-1abeled CD3+4+8 -  cells  compared 
with CD3 +  4-8 + thymocytes, although the total fraction of 
phenotypically mature thymocytes never rose above 10% of 
the entire PKH2-1abeled population (Fig. 4 D). The relative 
ratio of PKH2-1abeled CD4 and CD8 single positive thymo- 
cytes at the latter time points were similar to those seen in 
SCID-hu thymic grafts in which the ratio of phenotypically 
mature CD3 +  4 +  8- and CD3 +  4- 8 + cells was slightly more 
than 2:1, with CD4 + single positives comprising 12  _+  7% 
of thymocytes, and CD8 single positive thymocytes  comprising 
5  +  6%  of the thymocyte population (17). 
The exponential decline in PKH2 signal of donor-derived 
TN thymocytes suggested that TN cells retained the poten- 
tial for limited self-renewal, since a proportion of the TN 
progeny cells remain phenotypicatly TN, and demonstrate 
progressively lower intensities of the PKH2 label, consistent 
with cell division (Figs. 1 and 8 A). Based on the initial rate 
of decline of the ln[PKH2 fluorescence signal] of donor-derived 
PKH2-1abeled TN thymocytes at 24 h after intrathymic in- 
jection, we estimated the length of the cell cycle for the TN 
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sumes that the PKH2-1abeled TN cells constitute a uniform 
population with respect to the fraction of cells in cell cycle 
and their cell cycle length. After the in vivo growth of PKH2- 
labeled TN cells, the variance of their fluorescent signal is 
too large to detect subpopulations of PKH2-1abeled TN cells 
that could have different cell cycle kinetics. Thus the average 
cell cycle length of 24 h, that we calculated for the TN popu- 
lation as a whole, could represent a combination of shorter 
and longer cell cycle lengths of subpopulations of TN that 
are dividing more and less rapidly, respectively. The change 
in the slope of the decline in the ln[PKH2 signal]  at later 
time points (Fig.  8 B) suggests that the PKH2-1abeled TN 
population is indeed somewhat heterogeneous, and contains 
a subpopulation(s) of cells that are nondividing, or dividing 
at a slower rate. Therefore, the decline of the ln[PKH2 signal] 
is best approximated by a second degree polynomial equa- 
tion rather than a first degree polynomial (linear) equation. 
As the PKH2-1abeled TN differentiated, they constituted a 
diminished fraction of the total  PKH2 +  population.  We 
have estimated that, on the average, ,o30% of the TN cells 
differentiate into  more mature cells,  whereas 70%  of the 
progeny remain phenotypically TN after each cell division. 
Compared with the corresponding TN population,  the 
lower intensities of PKH2 label  in the thymocyte popula- 
tions of intermediate differentiation (CD3-4+8 - , 3-4+8 + , 
and 3+4+8 +)  24  h  after intrathymic injection of PKH2- 
labeled TN thymocytes, suggested that either (a) more cell 
divisions had occurred in these thymic subpopulations com- 
pared with those TN cells that remained phenotypically un- 
changed; or (b) the subpopulations of TN that differentiate 
to more mature phenotypes undergo more rapid cell division 
than those PKH2-1abeled cells that remain phenotypically TN 
(Fig. 8 B). Conclusions from several studies on murine thymo- 
cyte kinetics (20-23) which demonstrate more rapid cell cy- 
cling  in  the  CD3-4-8 +  population  compared with  the 
more immature TN population (23)  support the idea that 
thymocytes of intermediate levels of differentiation (between 
TN and the phenotypically mature cells) may divide more 
rapidly than the TN population (56). 
After the injection of PKH2-1abeled TN cells, a PKH2- 
labeled  CD3-4+8 -  population  rapidly  appeared  in  the 
thymus, largely preceding the appearance of larger numbers 
of CD3- 4 +  8 + and CD3 +  4 +  8 + cells (Figs. 3 F, 4 B and 4 
C).  Sorted,  PKH2-1abeled CD3-4+8 -  cells differentiated 
rapidly in vivo, to CD3- 4 +  8 + and CD3 +  4 +  8 + populations 
(Fig.  6), indicating that the CD3-4+8 -  population was a 
sequential  intermediate  between  TN  and  CD3-4 +8 + / 
CD3+4+8 + populations. These results are in contrast to the 
differentiation of mouse thymocytes in C57BL  strains,  in 
which the differentiation of TN thymocytes proceeds pri- 
marily through a CD3-4-8 + intermediate to the CD4 +  8 + 
population (9), but are similar to the pathway described in 
CBA mouse strains,  in which TN  differentiate through a 
3-4+8 -  intermediate as well (57-59). Murine CD3-4-8 + 
and CD3-4 +  8-  thymocytes have been shown to be large, 
blast cells, cortisone sensitive,  and concentrated in the outer 
cortex (60). 
Spitz et al. (26) have demonstrated that the human post- 
natal  3-4+8 +  population  can  be  subdivided  into 
CD3-4+8o~+Sfl -  and CD3-4+8c~+8fl+  populations,  and 
that the expression of CDSc~ + precedes the expression of 
CDSfl when TN tbymocytes are cultured in vitrcx  These 
authors noted a CD3-4+8c~ -  population,  that is presum- 
ably identical to the CD3-4 +  8- population described in the 
present study, as we have used an antibody to CDS, Leu-2a, 
that recognizes CDSc~.  An additional pathway of human 
thymic differentiation from CD3-4-8-  cells to CD4+8 + 
without  going  through the CD3-4+8 -  immature inter- 
mediate is possible, and cannot be excluded by our data. How- 
ever, at least 50% of TN thymocytes appear to mature via 
a CD3-4+8 -  intermediate (Fig. 4). In addition, small num- 
bers of CD3 +  4- 8- cells appeared at later time points, which 
contributed to the overall CD4-8-  population. Because of 
the rarity of the CD3 +  4- 8- cells, the developmental path- 
way that leads to this thymic subset could not be determined. 
The maturation of human TN thymocytes in vivo via a 
CD3-4 +  8- intermediate correlates well with in vitro differ- 
entiation  studies  of TN  and  CD3-4+8 -  thymocytes on 
short-term, heterologous, human-stromal cell cultures (Lie- 
berman, M., A. Sen-Majumdar, D. L. Kraft, I. L. Weissman, 
and E.  K.  Waller,  unpublished observations). 
The expression of CD4 at an early stage of intrathymic 
T cell maturation could potentially play a role in HIV infec- 
tion of the thymus (61). This is testable,  as SCID-hu thymic 
grafts sustain productive HIV infection (62),  and in the in- 
fected thymuses, eventual depletion of CD4 + cells occurs 
(62a). Furthermore, a rapidly cycling immature CD3-4 +  8- 
intermediate may play a role in lymphomagenesis. An induc- 
ible routine T  cell lymphoma corresponding to the imma- 
ture murine CD3-4-8 + thymocyte subset has recently been 
reported (63). Two CD3-4 +  8- human lymphomas have re- 
cently been described in immunosuppressed organ transplant 
recipients, and may represent the neoplastic analog of the 
CD3-4+8 -  thymic intermediate (64). 
The technique of FACS  |  sorting based on relative DNA 
content (HOECHST staining) combined with PKH2 labeling, 
allowed an investigation of the relative potential of dividing 
vs. nondividing populations to differentiate. CD4 +  8 + cells 
were sorted on the basis of their DNA content, PKH2 la- 
beled, and injected into thymic grafts (Fig. 7). The subpopu- 
lation in cell cycle (DNA content >2 N) differentiated into 
thymocytes of a mature phenotype, whereas CD4 +  8 + cells 
not engaged in DNA synthesis failed to differentiate to a 
significant degree in vivo (Fig.  6). It has been reported that 
the majority of dividing mouse CD4 +  8 + blasts express low 
levels of TCR/CD3 (65). Taken together, these data indicate 
that the nondividing subset of small CD4 +  8 + cells are des- 
tined to die intrathymically, and that only those CD4+8 + 
cells that have received mitogenic stimuli (presumably as a 
result of engagement of the low numbers of TCR expressed 
on their surfaces) are able to differentiate further into thymo- 
cytes of more mature phenotypes (positive selection) (10). 
Fig. 9 presents a model for a differentiation pathway of 
human TN fetal thymocytes which summarizes our data. The 
ability to observe human T  cell differentiation in vivo pro- 
274  In Vivo Differentiation of Human Thymocytes vides a means to examine the developmental ontogeny of TN 
thymocyte populations of more defined phenotypes (such as 
CD34 +  pediatric  and  adult  thymocytes). Other  develop- 
mental phenomena can be examined, such as extrathymic T 
cell differentiation, and the effects of systemic/physiologic vari- 
ables on thymocyte differentiation (39). 
Intrathymic transfer of PKH2-1abeled  human thymocyte 
populations into the SCID-hu mouse model offers a useful 
in vivo model for the study of short-term human T  cell 
differentiation. Use of such a system should prove useful in 
the delineation and ontogeny of various progenitor cell popu- 
lations in the thymus, and other human tissues that can be 
engrafted into SCID mice (66). 
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